60 related articles for article (PubMed ID: 33031637)
1. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
Jia P; Wei E; Liu H; Wu T; Wang H
IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
[TBL] [Abstract][Full Text] [Related]
3. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RAD51-AS1/miR-29b/c-3p/NDRG2 crosstalk repressed proliferation, invasion and glycolysis of colorectal cancer.
Li C; Wang P; Du J; Chen J; Liu W; Ye K
IUBMB Life; 2021 Jan; 73(1):286-298. PubMed ID: 33314669
[TBL] [Abstract][Full Text] [Related]
6. lncRNA SEMA3B-AS1 Inhibits miR-513c-5p to Regulate the Progression of Triple-negative Breast Cancer.
Yu H; Wu Y; Huang J; Li S
Anticancer Res; 2023 Dec; 43(12):5475-5484. PubMed ID: 38030196
[TBL] [Abstract][Full Text] [Related]
7. PAX8-AS1 knockdown facilitates cell growth and inactivates autophagy in osteoblasts via the miR-1252-5p/GNB1 axis in osteoporosis.
Huang C; Li R; Yang C; Ding R; Li Q; Xie D; Zhang R; Qiu Y
Exp Mol Med; 2021 May; 53(5):894-906. PubMed ID: 34012023
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
[TBL] [Abstract][Full Text] [Related]
9. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.
Xu Y; Qiu Z; Chen J; Huang L; Zhang J; Lin J
Drug Deliv Transl Res; 2024 Jul; 14(7):2003-2018. PubMed ID: 38161194
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.
Qin S; Ning M; Liu Q; Ding X; Wang Y; Liu Q
Bioengineered; 2021 Dec; 12(1):5125-5137. PubMed ID: 34374638
[TBL] [Abstract][Full Text] [Related]
11. miR-141-3p Enhanced Radiosensitivity of CRC Cells.
Peng L; Li P; Peng Z
Comb Chem High Throughput Screen; 2024; 27(1):118-126. PubMed ID: 37143278
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma.
Zhao K; Wang X; Jin Y; Zhu X; Zhou T; Yu Y; Ji X; Chang Y; Luo J; Ni X; Guo Y; Yu D
Cell Death Dis; 2024 Jan; 15(1):5. PubMed ID: 38177154
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit.
Tao Y; Zhang J; Chen L; Liu X; Yao M; Zhang H
Cell Death Dis; 2021 May; 12(6):510. PubMed ID: 34006845
[TBL] [Abstract][Full Text] [Related]
14. NR1D1-transactivated lncRNA NUTM2A-AS1 promotes chemoresistance and immune evasion in neuroblastoma via inhibiting B7-H3 degradation.
Xiang T; Li Y; Liu G; Li X
J Cell Mol Med; 2024 May; 28(10):e18360. PubMed ID: 38785199
[TBL] [Abstract][Full Text] [Related]
15. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
[TBL] [Abstract][Full Text] [Related]
16. miRNA326-5p Targets DKC1 Gene to Regulate Apoptosis-Related Proteins and Intervene in the Development of Neuroblastoma.
Wang XH; Zhang SF; Wu HY; Gao J; Wang L; Wang XH; Gao TH
Anal Cell Pathol (Amst); 2023; 2023():6761894. PubMed ID: 37426487
[TBL] [Abstract][Full Text] [Related]
17. BHLHE40, a potential immune therapy target, regulated by FGD5-AS1/miR-15a-5p in pancreatic cancer.
Qi W; Liu Q; Fu W; Shi J; Shi M; Duan S; Li Z; Song S; Wang J; Liu Y
Sci Rep; 2023 Sep; 13(1):16400. PubMed ID: 37773521
[TBL] [Abstract][Full Text] [Related]
18. EGCG Disrupts the LIN28B/Let-7 Interaction and Reduces Neuroblastoma Aggressiveness.
Cocchi S; Greco V; Sidarovich V; Vigna J; Broso F; Corallo D; Zasso J; Re A; Rosatti EF; Longhi S; Defant A; Ladu F; Sanna V; Adami V; D'Agostino VG; Sturlese M; Sechi M; Aveic S; Mancini I; Sighel D; Quattrone A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732012
[TBL] [Abstract][Full Text] [Related]
19. miR-124 and VAMP3 Act Antagonistically in Human Neuroblastoma.
Zhang X; Yang C; Meng Z; Zhong H; Hou X; Wang F; Lu Y; Guo J; Zeng Y
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834325
[TBL] [Abstract][Full Text] [Related]
20. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB).
Bailey AW; Suri A; Chou PM; Pundy T; Gadd S; Raimondi SL; Tomita T; Sredni ST
Bioengineering (Basel); 2018 Nov; 5(4):. PubMed ID: 30400339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
